Application for production of yiqitongbi capsule, a new heavyweight drug of foci pharmaceutical, was accepted
-
Last Update: 2014-09-03
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
According to the public information, Yiqi Tongbi capsule is a kind of traditional Chinese medicine compound preparation product used to treat coronary heart disease It obtained the approval of clinical trial of drugs in March 2006 The results of clinical trials show that the therapeutic effect of the drug for coronary heart disease and angina pectoris is better than most famous brands on the market CFDA website shows that at present, there is no enterprise in China to produce Yiqi Tongbi capsule, and only foci pharmaceutical has applied for production Foci pharmaceutical pointed out that the similar products of Yiqi Tongbi capsule include buxintong and Fufang Danshen dropping pills, which have a good market prospect and have a positive impact on the company's long-term development and performance growth Industry insiders predict that once Yiqi Tongbi capsule comes out, it will take a piece of the Chinese traditional medicine market of nearly 10 billion yuan per year As the concentration of cardiovascular and cerebrovascular traditional Chinese medicine market is very scattered, the top three brands only account for 10% of the share, so the rising stars still have room to catch up.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
